猛健樂 tirzepatide 猛健樂的常見副作用與安全性- 黃柏誠醫師 猛健樂Mounjaro減重新選擇】GLP-1+GIP雙效瘦瘦筆｜代謝重啟、體脂燃燒、每週一次| 佳思優整形醫美診所
Description
Neither is a shortcut
Results from these clinical studies demonstrated significant improvements in glycaemic control, as indicated by notable reductions in glycated haemoglobin levels (-1.87% to -2.59%, -20 to -28 mmol/mol)
In clinical trials, around 4% to 14% of participants reported headaches on Mounjaro or Zepbound
That makes it hard to know if Mounjaro directly caused the problems, or if it was simply because the mothers werent eating enough to support healthy fetal development
